Publications
134
Citations
1,981
Est. group size
—
Recurring co-author estimate
Active years
21
Publishing since 2005
Diego de Miguel-Pérez studies lung cancer and other solid tumors, focusing on 'liquid biopsy' techniques that detect cancer-related material (like circulating tumor cells, extracellular vesicles, and cell-free DNA) in blood samples instead of tissue biopsies. This work aims to help predict how tumors will respond to treatments such as immunotherapy and chemoradiotherapy, and to track disease progression and drug resistance over time. Some of the work also touches on COVID-19 biomarkers and outcomes in patients with cancer or thoracic disease.
Publication output has grown substantially since 2017, rising from a handful of papers per year to a peak in 2021 and 2023, with continued strong activity in 2024 and 2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Plasma extracellular vesicles as biomarkers of primary versus acquired resistance to immune checkpoint inhibitors (ICI) in patients (pts) with solid tumors.
Journal of Clinical Oncology · 2025
- Correction: Hernández-Pedro et al. Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Thoracic Malignancies. Vaccines 2023, 11, 1612
Vaccines · 2025
- Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors
Critical Reviews in Oncology/Hematology · 2024
- Extracellular vesicles containing SARS‐CoV‐2 proteins are associated with multi‐organ dysfunction and worse outcomes in patients with severe COVID‐19
Journal of Extracellular Vesicles · 2024
- Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC
Journal of Experimental & Clinical Cancer Research · 2024
- The role of liquid biopsy as a catalyst for sustained progress in precision oncology – Perspective of the young committee of the international society of liquid biopsy
The Journal of Liquid Biopsy · 2024
- Facing an un-met need in lung cancer screening: The never smokers
Critical Reviews in Oncology/Hematology · 2024
- Clinical utility of Next Generation Sequencing of plasma cell-free DNA for the molecular profiling of patients with NSCLC at diagnosis and disease progression
Translational Oncology · 2024
- Engineered extracellular vesicles for cancer drug delivery and therapeutics
Current Opinion in Physiology · 2024
- Unveiling pandemic patterns: a detailed analysis of transmission and severity parameters across four COVID-19 waves in Bogotá, Colombia
BMC Global and Public Health · 2024
- Resectable Non-Small Cell Lung Cancer Heterogeneity and Recurrence Assessed by Tissue Next-Generation Sequencing Genotyping and Circulating Tumor Cell EZH2 Characterization
Archivos de Bronconeumología · 2024
- Unveiling Pandemic Patterns: A Detailed Analysis of Transmissibility and Severity Parameters Across Four COVID-19 Waves in Bogotá, Colombia
Research Square · 2024
- 2298: Plasma extracellular vesicle miRNA-30c, positive predictor in NSCLC treated with chemoradiotherapy.
Radiotherapy and Oncology · 2024
- Efecto de distintos grados de estrés hídrico en el tamaño de la aceituna y en la formación de aceite
2024
- Respuesta a largo plazo del olivo a diferentes estrategias de riego deficitario
2024
- Annals of Oncology×7
- The Journal of Liquid Biopsy×7
- Critical Reviews in Oncology/Hematology×5
- Journal of Thoracic Oncology×5
- Clinical Lung Cancer×3
- Hossein Borghaei
Medicine · The Ohio State University
- David P. Carbone
Medicine · The Ohio State University
- Ai Ni
Medicine · The Ohio State University
- Gregory A. Otterson
Medicine · The Ohio State University
- Dwight H. Owen
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile